Response assessment in lymphoma

Clinical Radiology
F A Hampson, A S Shaw

Abstract

The lymphomas are a heterogeneous group of malignant diseases. They are divided into two broad groups: Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). Patients suffering from HD and NHL can be cured by appropriate chemotherapy and/or radiotherapy. Accurate staging and response assessment is essential to guide management decisions. The International Workshop Group (IWG) criteria, published in 1999, have become the widely accepted standard for response assessment in NHL. Although the IWG criteria have proved extremely useful in the standardization of treatment response, they do have a number of limitations. As a consequence of this, together with advances in functional imaging, revised criteria have been published recently. The aim of this review is to describe the evidence supporting the available imaging techniques, the limitations of each technique, and how these should be applied in clinical practice. We briefly review the corresponding response criteria for central nervous system (CNS) lymphomas, and take a look at novel imaging techniques that may play a role in the future.

References

May 1, 1995·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·T InoueD A Podoloff
Jul 27, 2000·The New England Journal of Medicine·R M PietermanH J Groen
Jan 18, 2005·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Toshiki KazamaHomer A Macapinlac
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malik E JuweidBruce D Cheson
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lauren E AbreyUNKNOWN International Primary CNS Lymphoma Collaborative Group
Aug 16, 2005·Seminars in Nuclear Medicine·Rodney J HicksJohn F Seymour
Aug 16, 2005·Seminars in Nuclear Medicine·Guy JerusalemGeorges Fillet
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma

❮ Previous
Next ❯

Citations

Dec 24, 2009·AJR. American Journal of Roentgenology·Carmel G CroninJohn F Bruzzi
Nov 26, 2010·AJR. American Journal of Roentgenology·Chang Woo ChunSung-Hwan Park
May 17, 2011·Future Oncology·Asim Afaq, Oguz Akin
Mar 11, 2011·World Journal of Gastroenterology : WJG·Prasanna GhimireLing Zhu
Jan 1, 2008·The Gulf Journal of Oncology·A H Elgazzar, E K Alenizi
Jul 31, 2012·Revista española de medicina nuclear e imagen molecular·A M Alvarez PáezA Serena Puig
Oct 1, 2008·PET Clinics·Gang ChengHongming Zhuang
Jul 19, 2011·Journal of Experimental & Clinical Cancer Research : CR·Nizar M MhaidatAhmad N Aldaher
Jun 24, 2009·Journal of Experimental & Clinical Cancer Research : CR·Lara C V HarrisonPrasun Dastidar
Jul 28, 2017·International Journal of Molecular Sciences·Senthilkumar KalimuthuByeong-Cheol Ahn
Apr 30, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mateen C MoghbelErik Mittra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Bruce D ChesonInternational Harmonization Project on Lymphoma
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Malik E JuweidImaging Subcommittee of International Harmonization Project in Lymphoma
© 2021 Meta ULC. All rights reserved